The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVast Res Share News (VAST)

Share Price Information for Vast Res (VAST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.215
Bid: 0.21
Ask: 0.22
Change: -0.015 (-6.52%)
Spread: 0.01 (4.762%)
Open: 0.23
High: 0.23
Low: 0.215
Prev. Close: 0.23
VAST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

Tue, 03rd May 2022 11:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Vast Resources PLC, up 50% at 0.51 pence, 12-month range 0.08p-10.00p. The Romania and Zimbabwe-focused miner says revenue more than doubled to USD2.3 million in the first quarter from USD970,465 in the fourth quarter. Reports increase in tons milled and in dry-metric-ton production at the Baita Plai polymetallic mine in Romania.

----------

Eneraqua Technologies PLC, up 10% at 280.00p, up 1.1% from November listing price of 277.00p. The energy and water efficiency services provider wins contract from the Indian state government of Uttarakhand to reduce carbon emissions and improve water efficiency. The northern state has a population of over 10 million people. Contract is worth GBP900,000 from the state's Department of Horticulture will see Eneraqua supply systems to 340 horticultural farms across the state.

----------

AIM - LOSERS

----------

Hutchmed (China) Ltd, down 15% at 208.00p, 12-month range 202.50p-656.00p. The US Food & Drug Administration has rejected the drugmaker's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA said the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
17 Mar 2021 14:44

TRADING UPDATES: Novacyt expands VersaLab with rapid Covid tests

TRADING UPDATES: Novacyt expands VersaLab with rapid Covid tests

Read more
27 Jan 2021 14:37

Vast Resources Interim Loss Narrows Amid Favourable Currency Movements

Vast Resources Interim Loss Narrows Amid Favourable Currency Movements

Read more
22 Jan 2021 14:47

EXECUTIVE CHANGES: AIB Taps Former DCC CFO As Non-Executive Director

EXECUTIVE CHANGES: AIB Taps Former DCC CFO As Non-Executive Director

Read more
10 Dec 2020 11:11

Vast completes first commercial sale from Baita Plai, flags second sale

(Sharecast News) - Production and development company Vast Resources updated the market on the first commercial sale of concentrate produced at its Baita Plai Polymetallic Mine in Romania on Thursday.

Read more
9 Dec 2020 09:51

Vast Resources signs asset-backed term sheet, raises £4.85m

(Sharecast News) - Mining company Vast Resources announced on Wednesday that its term sheet with an unnamed international banking institution had now been agreed between the bank's executive team and the company.

Read more
23 Nov 2020 12:03

Vast Resources to complete first Baita Plai concentrate sale

(Sharecast News) - Vast Resources said on Monday that the first commercial sale of concentrate produced at its Baita Plai Polymetallic Mine in Romania is expected to conclude on 25 November.

Read more
16 Nov 2020 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Nov 2020 10:50

Vast Resources increases exploration target at Baita Plai

(Sharecast News) - Vast Resources announced an increase to the exploration target for its Baita Plai Polymetallic Mine in Romania on Friday.

Read more
29 Oct 2020 19:08

IN BRIEF: Vast Resources Loss Narrows; Publishes Baita Plai Report

IN BRIEF: Vast Resources Loss Narrows; Publishes Baita Plai Report

Read more
26 Oct 2020 19:06

IN BRIEF: Vast Resources Plans Fundraise; Baita Plai Report This Week

IN BRIEF: Vast Resources Plans Fundraise; Baita Plai Report This Week

Read more
26 Oct 2020 13:33

Vast Resources makes progress on financing at Baita Plai

(Sharecast News) - Vast Resources updated the market on its recent operational and financing progress on Monday, announcing a placing to raise £1.75m at 0.16p per share, to provide additional working capital following the recent cash settlement of its conversion notice, and funding through to payment in full from first copper sales to Mercuria.

Read more
22 Oct 2020 21:46

IN BRIEF: Vast Resources's Baita Plai Flotation Plant Starts Operation

IN BRIEF: Vast Resources's Baita Plai Flotation Plant Starts Operation

Read more
22 Oct 2020 10:58

Vast Resources begins flotation plant production at Baita Plai

(Sharecast News) - Mining company Vast Resources announced on Thursday that the flotation plant at Baita Plai was now fully operational, and producing concentrate.

Read more
12 Oct 2020 13:51

Vast Resources reports progress with Baita Plai financing process

(Sharecast News) - Mining company Vast Resources updated the market on progress on the asset-backed debt financing process linked to its Baita Plai Polymetallic Mine in Romania on Monday.

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.